Cutaneous tumors in organ transplant recipients;Tumeurs cutanées chez les greffés d'organe

Presse Medicale

Volumn 31, Issue 40, 2002, Pages 1895-1903

  Euvrard, Sylvie ^a   Kanitakis, Jean ^a   Claudy, Alain ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOSARCOMA; CANCER RISK; DISEASE TRANSMISSION; FIBROXANTHOMA; HEREDITY; HISTIOCYTOMA; HUMAN; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; LEIOMYOSARCOMA; MELANOMA; MERKEL CELL TUMOR; ORGAN PRESERVATION; ORGAN TRANSPLANTATION; PAPILLOMA VIRUS; PREDICTION; PREVALENCE; PROGNOSIS; RECIPIENT; REVIEW; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; ULTRAVIOLET RADIATION; VIRUS INFECTION;

CARCINOMA, SQUAMOUS CELL; HUMANS; IMMUNOSUPPRESSION; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SKIN NEOPLASMS; TRANSPLANTATION IMMUNOLOGY;

EID: 0037153764     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Walder BK, Robertson MR, Jeremy D. Skin cancer and immunosuppression, Lancet 1971; ii: 1282-3.
2. Hartevelt MM, Bouwes Bavinck JN, Koote AMM et al. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation 1990; 49: 506-9.
3. Birkeland S, Storm HH, Lamm LU et al. Cancer risk after renal transplantation in nordic countries. Int J Cancer 1995; 60: 183-9.
4. Jensen P, Hansen S, Moller B et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999; 40: 177-86.
5. Euvrard S, Kanitakis J, Pouteil-Noble C et al. Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol 1995; 33: 222-9.
6. Ternesten-Bratel A, Kjellstrom C, Ricksten A. Specific expression of Epstein-Barr virus in cutaneous squamous cell carcinomas from heart transplant recipients. Transplantation 1998; 66: 1524-9.
7. Veness MJ, Quinn DI, Ong CS et al. Aggressive cutaneous malignancies following cardiothoracic transplantation. Cancer 1999; 85: 1759-64.
8. Caforio AL, Fortina AB, Piaserico S et al. Skin cancer in heart transplant recipients: Risk factor analysis and relevance of immunosuppressive therapy. Circulation 2000; 102: 222-7.
9. Frezza EE, Fung JJ, Van Thiel DH. Non-lymphoid cancer after liver transplantation. Hepatogastroenterology 1997; 44: 1172-81.
10. Jonas S, Rayes N, Neumann U et al. De Novo malignancies after liver transplantation using Tacrolimus-based protocols or Cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin. Cancer 1997; 80: 1141-50.
11. Jain AB, Yee LD, Nalesnik MA et al. Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation 1998; 66: 1193-200.
12. Bouwes-Bavinck JN, Hardie D, Green A et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia. Transplantation 1996; 61; 715-21.
13. Webb MC, Compton F, Andrews PA, Koffman CG. Skin tumours posttransplantation. A retrospective analysis of 28 years'experience at a single centre. Transplant Proc 1997; 29: 828-30.
14. Euvrard S, Kanitakis J, Pouteil-Noble C et al. Aggressive squamous cell carcinomas in organ transplant recipients. Transplant Proc 1995; 27: 1767-8.
15. Penn I. De novo malignancy in pediatric organ transplant recipients, Pediatr Transplantation 1998; 2: 56-63.
16. Euvrard S, Kanitakis J, Cochat P et al. Skin diseases in children with organ transplants. J Am Acad Dermatol 2001; 44: 932-9.
17. Hoyo E, Kanitakis J, Euvrard S et al. Proliferation characteristics of cutaneous squamous cell carcinomas developing in organ graft recipients. Arch Dermatol 1993; 129: 324-7.
18. Narvaez D, Kanitakis J, Euvrard S et al. Comparative nuclear morphometric analysis of aggressive and non-aggressive squamous cell carcinomas of the skin. Acta Derm Venereol 1997; 77: 115-17.
19. Kanitakis J, Narvaez D, Euvrard S et al. Proliferation markers Ki67 and PCNA in cutaneous squamous cell carcinomas: Lack of prognostic value. Br J Dermatol 1997; 136: 643-4.
20. Shell AGR, Flavel S, Disney APS et al. Cancer incidence in renal transplant patients treated with azathioprine or cyclosporine. Transplant Proc 1987; 19: 2214-16.
21. Hoshida Y, Tsukuma H, Yasunaga Y et al. Cancer risk after renal transplantation in Japan. Int J Cancer 1997; 71: 517-20.
22. Cowen EW, Billingsley EM. Awareness of skin cancer by kidney transplant patients. J Am Acad Dermatol 1999; 40: 697-701.
23. Kurimoto I, Streilein JW. UV-induced immunosuppression. In: Euvrard, S, Kanitakis J, Claudy A editors. Skin Diseases After Organ Transplantation. Paris: John Libbey Eurotext, 1998; 29-36.
24. Ducloux D, Carron PL, Rebibou JM et al. CD4 lymphopenia as a risk factor for skin cancers in renal transplant recipients, Transplantation 1998; 65: 1270-2.
25. Arends MJ, Benton EC, McLaren KM et al. Renal allograft recipients with high susceptibility to cutaneous malignancy have an increased prevalence of human papillomavirus DNA in skin tumours and a greater risk of anogenital malignancy. Br J Cancer 1997; 75: 722-8.
26. Euvrard S, Pouteil-Noble C, Kanitakis J et al. Successive occurrence of T-cell and B-cell lymphomas after renal transplantation in a patient with multiple cutaneous squamous cell carcinomas. N Engl J Med 1992; 327: 1924-7.
27. Kanitakis J, Euvrard S, Montazeri A et al. Atypical fibroxanthoma in a renal graft recipient. J Am Acad Dermatol 1996; 35: 262-4.
28. Dantal J, Hourmant M, Cantarovich D et al. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: Randomised comparison of two cyclosporin regimens, Lancet 1998; 351: 623-8.
29. Ramos HC, Reyes J, Abu-Elmagd K et al. Weaning of immunosuppression in long-term liver transplant recipients. Transplantation 1995; 59: 212-17.
30. Harwood CA, Surentheran T, McGregor JM et al. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol 2000; 61: 289-97.
31. De Jong-Tieben LM, Berkhout R, ter Schegget J et al. The prevalence of human papillomavirus DNA in benign keratotic skin lesions of renal transplant recipients with and without a history of skin cancer is equally high: A clinical study to assess risk factors for keratotic skin lesions and skin cancer. Transplantation 2000; 69: 44-9.
32. Boxman I, Berkhout R, Mulder L et al. Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers, J Invest Dermatol 1997; 108: 712-15.
33. Euvrard S, Chardonnet Y, Pouteil-Noble C et al. Association of skin malignancies with various and multiple carcinogenic and non carcinogenic human papillomaviruses in renal transplant recipients. Cancer 1993; 72: 2198-206.
34. McGregor JM, Berkhout RJM, Rozycka M et al. p53 mutations implicate sunlight in post-transplant skin cancer irrespective of human papillomavirus status. Oncogene 1997; 15: 1737-40.
35. Cairey-Remonnay S, Humbey O, Mougin C et al. TP53 polymorphism of exon 4 at codon 72 in cutaneous squamous ceil carcinoma and benign epithelial lesions of renal transplant recipients and immunocompetent individuals: Lack of correlation with HPV status, J Invest Dermatol 2002; 118: 1026-31.
36. Bouwes-Bavinck JN, Claas F, Hardie D et al. Relation between HLA antigens and skin cancer in renal transplant recipients in Queensland, Australia. J Invest Dermatol 1997; 108: 708-11.
37. Ramsay HM, Harden PN, Reece S et al. Polymorphisms in glutathione S-transferases are associated with altered risk of nonmelanoma skin cancer in renal transplant recipients. J Invest Dermatol 2001; 117: 251-5.
38. Euvrard S, Kanitakis J, Thivolet J et al. Retinoids for the management of dermatological complications of organ transplantation. Biodrugs 1997; 3: 176-84.
39. Magnone M, Holley J, Shapiro R et al. Interferon a-induced acute renal allograft rejection, Transplantation 1994; 59: 1068-70.
40. Dockrell DH, Kinghorn GR. Imiquimod and resiquimod as novel immunomodulators, J Antimicrob Chemother 2001; 48: 751-5.
41. Penn I. Cancers of the anogenital region in renal transplant recipients. Cancer 1986; 58: 611-16.
42. Euvrard S, Kanitakis J, Chardonnet Y et al. External anogenital lesions in organ transplant recipients. Arch Dermatol 1997; 133: 175-8.
43. Penn I. Malignant melanoma in organ allograft recipients. Transplantation 1996; 61: 274-8.
44. Lévêque L, Dalac S, Dompmartin A et al. Mélanome chez le transplanté. Ann Dermatol Venereol 2000; 127: 160-5.
45. Smith C, McGregor J, Barker J, Morris RW, Rigden SPA, MacDonald DM. Excess melanocytic nevi in children with renal allografts. J Am Acad Dermatol 1993; 28: 51-5.
46. Francés C, Lagrange S. Kaposi's sarcoma. In: Euvrard S, Kanitakis J, Claudy A, editors. Skin Diseases After Organ Transplantation. Paris: John Libbey Eurotext, 1998; 131-8.
47. Penn I. Kaposi's sarcoma in transplant recipients. Transplantation 1997; 64: 669-73.
48. Penn I. Sarcomas in organ allograft recipients. Transplantation 1995; 60: 1485-91.
49. Kanitakis J, Narvaez D, Claudy A. Expression of the CD34 antigen distinguishes Kaposi's sarcoma from pseudo-Kaposi's sarcoma (acroangiodermatitis). Br J Dermatol 1996; 134: 44-6.
50. Delabesse E, Oksenhendler E, Lebbé C et al. Molecular analysis analysis of clonality in Kaposi's sarcoma. J Clin Pathol 1997; 50: 664-8.
51. Rabkin CS, Jane S, Lash A et al. Monoclonal origin of multicentric Kaposi's sarcoma lesions. N Engl J Med 1997; 336: 988-93.
52. Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. N Engl J Med 1995; 332: 1181-5.
53. Lebbé C, Agbalika F, de Crémoux P et al. Detection of human herpesvirus 8 and human T-cell lymphotropic virus type 1 sequences in Kaposi sarcoma. Arch Dermatol 1997; 133: 25-30.
54. Francès C, Mouquet C, Marcellin AG et al. Outcome of kidney transplant recipients with previous human herpevirus-8 infection. Transplantation 2000; 69: 1776-9.
55. Regamey N, Tamm M, Wernli M et al. Transmission of Human herpesvirus 8 infection from renal-transplant donors to recipients. N Engl J Med 1998; 339; 1358.
56. Bottalico D, Santabosti Barbone G, Giancaspro V et al. Post-transplantation Kaposi's sarcoma appearing simultaneously in same cadaver donor renal transplant recipients. Nephrol Dial Transplant 1997; 12: 1055-7.
57. Medveczky MM, Horvath E, Lund T et al. In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpes virus. AIDS 1997; 11: 1327-32.
58. Euvrard S, Kanitakis J, Bosshard S et al. No recurrence of posttransplantation Kaposi's sarcoma three years after renal retransplantation. Transplantation 2002; 73: 297-9.
59. Souteyrand P, Fabricio L, d'Incan M. Cutaneous lymphomas. In: Euvrard S, Kanitakis J, Claudy A, editors. Skin Diseases After Organ Transplantation. Paris: John Libbey Eurotext, 1998; 131-8.
60. Heinzerling L, Urbanek M, Funk J et al. Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (Rituximab) in patients with primary cutaneous B-cell lymphoma. Cancer 2000; 89: 1835-44.
61. Penn I, First M. Merkel's cell carcinoma in organ recipients. Transplantation 1999; 68: 1717-21.
62. Uribe-Uribe N, Aviles-Salas A, Orozco-Estevez H et al. Leiomyosarcoma associated with Epstein-Barr virus in an adult with renal transplant (en espagnol). Rev Invest Clin 1998; 50: 255-8.
63. Kibe Y, Kishimoto S, Katoh N et al. Angiosarcoma of the scalp associated with renal transplantation. Br J Dermatol 1997; 136: 752-6.